150 related articles for article (PubMed ID: 15033782)
21. Clusterin mRNA expression in apoptotic and activated rat thymocytes.
Park JH; Park JS; Ju SK; Lee KB; Park YK; Kang MH; Na SY; You KH
Cell Res; 2003 Feb; 13(1):49-58. PubMed ID: 12643349
[TBL] [Abstract][Full Text] [Related]
22. Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen.
Miyake H; Hara I; Gleave ME; Eto H
Prostate; 2004 Dec; 61(4):318-23. PubMed ID: 15389725
[TBL] [Abstract][Full Text] [Related]
23. Studies of specific gene induction during apoptosis of cell lines conditionally immortalized by SV40.
Guénal I; Mignotte B
FEBS Lett; 1995 Nov; 374(3):384-6. PubMed ID: 7589576
[TBL] [Abstract][Full Text] [Related]
24. Prostate specific antigen and androgen receptor induction and characterization of an immortalized adult human prostatic epithelial cell line.
Webber MM; Bello D; Kleinman HK; Wartinger DD; Williams DE; Rhim JS
Carcinogenesis; 1996 Aug; 17(8):1641-6. PubMed ID: 8761420
[TBL] [Abstract][Full Text] [Related]
25. Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin.
Zellweger T; Miyake H; July LV; Akbari M; Kiyama S; Gleave ME
Neoplasia; 2001; 3(4):360-7. PubMed ID: 11571636
[TBL] [Abstract][Full Text] [Related]
26. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
Srivastava P; Russo J; Mgbonyebi OP; Russo IH
Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
[TBL] [Abstract][Full Text] [Related]
27. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate.
Lakins J; Bennett SA; Chen JH; Arnold JM; Morrissey C; Wong P; O'Sullivan J; Tenniswood M
J Biol Chem; 1998 Oct; 273(43):27887-95. PubMed ID: 9774400
[TBL] [Abstract][Full Text] [Related]
28. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
[TBL] [Abstract][Full Text] [Related]
29. The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression.
Caporali A; Davalli P; Astancolle S; D'Arca D; Brausi M; Bettuzzi S; Corti A
Carcinogenesis; 2004 Nov; 25(11):2217-24. PubMed ID: 15358631
[TBL] [Abstract][Full Text] [Related]
30. The leader sequence triggers and enhances several functions of clusterin and is instrumental in the progression of human prostate cancer in vivo and in vitro.
Zhang Q; Zhou W; Kundu S; Jang TL; Yang X; Pins M; Smith N; Jovanovic B; Xin D; Liang L; Guo Y; Lee C
BJU Int; 2006 Aug; 98(2):452-60. PubMed ID: 16879694
[TBL] [Abstract][Full Text] [Related]
31. Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.
Gleave M; Miyake H
World J Urol; 2005 Feb; 23(1):38-46. PubMed ID: 15770517
[TBL] [Abstract][Full Text] [Related]
32. The new anti-oncogene clusterin and the molecular profiling of prostate cancer progression and prognosis.
Bettuzzi S
Acta Biomed; 2003 Aug; 74(2):101-4. PubMed ID: 14509920
[No Abstract] [Full Text] [Related]
33. Role of clusterin in cell adhesion during early phases of programmed cell death in P19 embryonic carcinoma cells.
Fratelli M; Galli G; Minto M; Pasinetti GM
Biochim Biophys Acta; 1996 Apr; 1311(2):71-6. PubMed ID: 8630332
[TBL] [Abstract][Full Text] [Related]
34. Clusterin inhibits apoptosis by interacting with activated Bax.
Zhang H; Kim JK; Edwards CA; Xu Z; Taichman R; Wang CY
Nat Cell Biol; 2005 Sep; 7(9):909-15. PubMed ID: 16113678
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and functional analyses of nuclear clusterin, a cell death protein.
Leskov KS; Klokov DY; Li J; Kinsella TJ; Boothman DA
J Biol Chem; 2003 Mar; 278(13):11590-600. PubMed ID: 12551933
[TBL] [Abstract][Full Text] [Related]
36. Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.
Ho SM; Leav I; Ghatak S; Merk F; Jagannathan VS; Mallery K
Am J Pathol; 1998 Jul; 153(1):131-9. PubMed ID: 9665473
[TBL] [Abstract][Full Text] [Related]
37. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
[TBL] [Abstract][Full Text] [Related]
38. Acquisition of resistance to Fas-mediated apoptosis by overexpression of clusterin in human renal-cell carcinoma cells.
Miyake H; Hara S; Zellweger T; Kamidono S; Gleave ME; Hara I
Mol Urol; 2001; 5(3):105-11. PubMed ID: 11690557
[TBL] [Abstract][Full Text] [Related]
39. [Prevention of cell death in LNCaP cells by overexpression of clusterin].
Xin DQ; Zhu XH; Ai JK; Na YQ; Guo YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):154-8. PubMed ID: 15100733
[TBL] [Abstract][Full Text] [Related]
40. The retinoid antagonist MX781 induces clusterin expression in prostate cancer cells via heat shock factor-1 and activator protein-1 transcription factors.
Bayon Y; Ortiz MA; Lopez-Hernandez FJ; Howe PH; Piedrafita FJ
Cancer Res; 2004 Aug; 64(16):5905-12. PubMed ID: 15313936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
